Back
ProShares Ultra Nasdaq Biotechnology 10K Form
Sell
41
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
61.97
Seasonality Move:
14.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIB
BIB Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
ProShares Ultra Nasdaq Biotechnology Earnings Forecast
Key ProShares Ultra Nasdaq Biotechnology Financial Ratios
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | BIB |
| CUSIP: | 74347R |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BIB Technical Analysis vs Fundamental Analysis
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a Sell
The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.89. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.